# Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less

> **NCT05193253** · — · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 119 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Radiofrequency ablation
- **PROCEDURE:** Liver resection
- **PROCEDURE:** Liver transplantation

## Key facts

- **NCT ID:** NCT05193253
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02-01
- **Primary completion:** 2018-11-30
- **Final completion:** 2021-12-21
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193253, "Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05193253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*